Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Trevi Therapeutics Inc (NQ: TRVI )

2.460 +0.130 (+5.58%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 45,202
Open 2.330
Bid (Size) 2.450 (4)
Ask (Size) 2.480 (3)
Prev. Close 2.330
Today's Range 2.300 - 2.610
52wk Range 0.4600 - 4.683
Shares Outstanding 59,922,945
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Trevi Therapeutics, Inc. Discusses Progress and 2022 Success of Clinical Studies for Its Investigational Oral Therapy Haduvio(TM) with The Stock Day Podcast
Phoenix, Arizona--(Newsfile Corp. - January 25, 2023) - The Stock Day Podcast welcomed Trevi Therapeutics, Inc. (NASDAQ: TRVI) ("the Company"),... 
Via Newsfile
Why Manchester United Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
Gainers COMSovereign Holding Corp. (NASDAQ: COMS) shares rose 58.4% to $0.1069 in pre-market trading after gaining more than 16% on Tuesday. 
Via Benzinga

Performance

YTD
+21.18%
+21.18%
1 Month
+27.46%
+27.46%
3 Month
+24.24%
+24.24%
6 Month
-23.60%
-23.60%
1 Year
+285.76%
+285.76%

More News

Read More
Earnings Outlook For Trevi Therapeutics, Inc. - Common Stock
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Trevi Therapeutics Shares Jump After Complete Data From Chronic Cough Trial
Via Benzinga
Earnings Scheduled For August 11, 2022
Via Benzinga
Why Did Needham Lift Price Target For Trevi?
Via Benzinga
Earnings Scheduled For November 10, 2022
Via Benzinga
Trevi Therapeutics, Inc. Discusses Commercialization for Its Investigational Therapy, Haduvio, with The Stock Day Podcast
Via Newsfile
Exposures Product Safety
Why Trevi Therapeutics Shares Trading Higher Today?
Via Benzinga
Recap: Trevi Therapeutics Q1 Earnings
Via Benzinga
Why SOBR Safe Shares Surged Around 233%; Here Are 68 Biggest Movers From Yesterday
Via Benzinga
5 Penny Stocks to Buy on the Dip
Via InvestorPlace
Traders News Source Senior Editor Mark Roberts Interviews Jennifer Good CEO of Trevi Therapeutics
From Traders News Source
Via AccessWire
5 Best Performing Micro-Cap Stocks Through the First Half of 2022
Via Spotlight Growth
Topics Stocks
Exposures Fossil Fuels US Equities
Dow Jumps 150 Points; Icosavax Shares Plunge
Via Benzinga
Why Is Allena Pharmaceuticals Jumping By 207%? 45 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
This Healthcare Stock Surges Around 115%, Here's 74 Biggest Movers From Yesterday
Via Benzinga
Palantir (PLTR) Stock Dips Despite 2 New Projects
Via InvestorPlace
Trevi Therapeutics (TRVI) Spikes 20% on Positive Clinical Data
Via InvestorPlace
Why U.S. Stocks Are Trading Higher, GDP Report And More
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
34 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Earnings Scheduled For May 12, 2022
Via Benzinga
51 Biggest Movers From Thursday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.